The finding of elevated anti-neuronal autoantibodies in our small sample of those with a prior history of Lyme Disease, if replicated in a larger sample, suggests an immune priming effect of repeated infection; the CaMKII activation suggests that antineuronal antibodies have functional significance. This evidence concerns the gene CAMK2G and Lyme disease.